Management of Headache in Children Under 5 Years

As per IAP (Indian Academy of Pediatrics) and AAP (American Academy of Pediatrics) Guidelines

IMPORTANT PREAMBLE: Why Children Under 5 are Different

• Primary headaches (migraine, tension-type) do exist under age 5 but secondary causes must be excluded first
• Migraine attacks in young children are often bilateral (frontal/temporal), shorter in duration, and associated with pallor and sleep
• The peak incidence of headache under 5 years is very low (3% at ages 3-7, Tintinalli's EM)

STEP 1 - INITIAL EVALUATION AND CLASSIFICATION

History (from parent/caregiver)

• Location, character, severity, duration, frequency
• Associated symptoms: nausea, vomiting, photophobia, phonophobia, visual changes, pallor
• Behavioral clues: seeking a dark/quiet room, holding head, crying, stopping play
• Triggers: missed meals, poor sleep, stress, fever, head trauma
• Family history of migraine
• New vs. recurring headache; any progression

Physical Examination

• Full neurological exam including optic fundus (papilledema)
• Head circumference measurement (IAP/Bradley & Daroff)
• Vital signs (BP - hypertension), temperature
• Meningeal signs
• Developmental milestones

STEP 2 - RED FLAG IDENTIFICATION

IAP "SNOOPY" Red Flag Mnemonic

AAP Red Flags (aligned)

• Headache awakening from sleep or worse on waking
• Headache with exertion or Valsalva
• Isolated occipital location (may suggest space-occupying lesion - urgent MRI)
• Side-locked headaches (may suggest trigeminal autonomic cephalalgia or mass)
• Fever with neck stiffness or altered level of consciousness (consider meningitis)
• Neurological deficit, papilledema, seizures

STEP 3 - INVESTIGATIONS

Neuroimaging

• Abnormal neurological examination or coexisting seizures
• Recent onset of severe headache in a child under 5
• Age < 3 years with any headache (Bradley & Daroff: "reasonable to perform neuroimaging for new headache in child < 6 years")
• Change in type or character of headache
• Occipital-based or side-locked headaches
• Features of raised ICP (AAP)
• Headache onset < 1 month, absent family history of migraine, progressive course

• Recurrent headaches with normal examination and typical primary headache features

Other Investigations (IAP - Table 3: condition-specific)

• CBC, CRP/ESR - if systemic illness suspected
• CSF examination - if CNS infection suspected or to measure opening pressure (idiopathic intracranial hypertension)
• Blood pressure - mandatory in all young children with headache
• EEG - not recommended routinely for episodic headaches (IAP)

STEP 4 - MANAGEMENT OF SECONDARY HEADACHE

STEP 5 - MANAGEMENT OF PRIMARY HEADACHE

A. Non-Pharmacological / Lifestyle Measures (FIRST LINE - Both IAP and AAP)

• Adequate water intake; school note for water bottle and extra bathroom breaks
• Age-appropriate sleep duration: 10-12 hours for young children
• Headache diary to identify patterns, triggers, severity, medication use
• Treat headache early before it becomes severe

B. Acute/Abortive Pharmacological Treatment

Note: Triptans are generally not approved or recommended for children under 6 years. Acute management in under-5 age group relies primarily on analgesics.

• Give with 24-32 oz of fluids (if no significant nausea)
• Limit analgesic use to ≤3 days/week to prevent Medication Overuse Headache (analgesic rebound)
• Opioids should be avoided

• Rest in a quiet, dark room
• Sleep (often terminates migraine in young children)
• IV hydration if presenting to ED
• Cold/warm compress to head

C. Emergency / Inpatient Acute Management (Severe/Status Migrainosus)

Dihydroergotamine (DHE) and most triptans are not used in children under 6 due to age restrictions and safety profile.

D. Preventive (Prophylactic) Treatment

• ≥1 headache per week or >3 headaches per month
• Prolonged and severe headaches even if infrequent
• Abortive treatment fails, is overused, or is contraindicated

Most preventive agents are used in children > 6 years due to limited evidence and safety data in under-5 age group. Use in children under 5 requires specialist (pediatric neurologist) guidance.

E. Complementary / Biobehavioral Treatments (IAP Recommended)

• Biofeedback therapy
• Relaxation techniques
• Cognitive Behavioral Therapy (CBT) - endorsed in AAN 2019 guidelines (reaffirmed 2025) especially in combination with pharmacological prophylaxis
• Acupuncture, massage therapy
• Hypnosis

STEP 6 - REFERRAL TO PEDIATRIC NEUROLOGIST

IAP and AAP indications:

• Any red flag present (SNOOPY criteria)
• Abnormal neurological examination
• Age < 3 years with persistent headache
• Headaches continuing despite lifestyle + first-line pharmacotherapy
• Need for preventive therapy in children under 5
• Diagnosis remains uncertain
• Suspected space-occupying lesion on imaging

Summary Algorithm (IAP Flowchart Basis)

Child <5 years with Headache
         ↓
Detailed History (parent) + Physical/Neurological Exam
         ↓
Red Flags present (SNOOPY)?
  YES → Investigate (MRI Brain, LP, BP, labs as indicated)
        → Treat underlying cause
        → Refer to Pediatric Neurologist
  NO  ↓
Classify: Primary vs. Secondary
         ↓
Secondary → Treat etiology (URTI, fever, trauma, etc.)
         ↓
Primary headache (migraine/TTH) suspected
         ↓
1. SMART lifestyle modifications + Headache diary
2. Acute: Paracetamol 15 mg/kg OR Ibuprofen 10 mg/kg
          + Rest/dark/quiet room + Fluids
3. Analgesic ≤3 days/week to prevent MOH
4. If ≥1 headache/week → Consider prophylaxis
   (Cyproheptadine or Melatonin preferred in <5 yrs)
   + Refer to Pediatric Neurologist

Key Points Specific to Under-5 Age Group

1. Headache under 3 years is a red flag - always neuroimaging (Bradley & Daroff, IAP)
2. Triptans are NOT approved for children under 6 years - avoid
3. Opioids are strictly avoided (AAP)
4. Cyproheptadine is the most commonly used prophylactic in young Indian children (IAP)
5. Paracetamol and ibuprofen are the only safe acute analgesics in this age group
6. Non-pharmacological measures (sleep, hydration, nutrition, dark room) are the foundation
7. Parental history is essential as the child cannot self-report pain characteristics
8. Prevent medication overuse - counsel parents strictly on frequency limits
9. Any behavioral change, sensorium change, or neurological sign = emergency evaluation
10. AAN 2019 Pharmacologic Treatment for Pediatric Migraine Prevention (endorsed by AAP, reaffirmed October 2025) is the current reference for prophylaxis decisions

Me (Orris) vs. Google Gemini

What I Am

Key Differences

Where Google Gemini Has an Edge

• Tightly integrated with Google Search - very current web results
• Native integration with Google Workspace (Docs, Sheets, Gmail)
• Multimodal image/video generation (Imagen, Veo)
• Broader consumer ecosystem

Where Orris Has an Edge

• Verified medical textbook citations - not just training data
• Live PubMed evidence retrieval with PMID citations
• Specialist guidelines (IAP, AAP, AAN, etc.) with source traceability
• Creates downloadable clinical documents, spreadsheets, presentations
• Domain skills that reduce hallucination on specialized topics

Dedicated Pediatrics Books in My Library

Other Books With Rich Pediatric Content

Honest Assessment

• Use Harriet Lane (drug dosing, protocols) and AAP Red Book (infectious diseases)
• Draw on pediatric chapters in emergency medicine, neurology, and pharmacology textbooks
• Access IAP's online published chapters via web search (as I did for the headache management plan)
• Search PubMed live for current AAP/IAP/AAN guidelines and evidence

Pediatric Proteinuria

Sources: Harriet Lane Handbook (23rd ed.) + Rosen's Emergency Medicine + Campbell-Walsh Urology

1. Definitions (Harriet Lane, p. 701)

2. Normal Urine Protein-to-Creatinine Ratio (Harriet Lane / Rosen's)

First morning void UPr:UCr is most accurate. Child must empty bladder before bed and immediately on waking.

3. Dipstick Interpretation (Rosen's EM, Table 168.3)

4. Causes of Proteinuria (Harriet Lane Box 19.1 / Rosen's Table 168.4)

Transient (benign)

Orthostatic

Glomerular Diseases

• Idiopathic (minimal change) nephrotic syndrome
• Focal segmental glomerulosclerosis (FSGS)
• Membranous nephropathy
• Membranoproliferative glomerulonephritis
• Diabetic nephropathy, sickle cell nephropathy

• Acute postinfectious GN (post-streptococcal)
• IgA nephropathy
• Henoch-Schonlein Purpura nephritis
• Lupus nephritis
• Alport syndrome
• Reflux nephropathy

Tubular Causes

5. Clinical Features (Rosen's EM)

• Edema - periorbital (early morning), lower extremities, genital area
• History of preceding streptococcal infection (pharyngitis 1-3 weeks prior, skin 3-6 weeks prior)
• Weight gain from fluid retention
• Decreased urine output
• Joint pain or rash - suggests autoimmune (lupus, HSP)
• Family history of kidney disease or autoimmune conditions
• Blood pressure - hypertension suggests glomerular disease

6. Investigations

For Mild Proteinuria (≤ 2+ on dipstick, Rosen's)

• No emergent workup needed
• Repeat first morning UPr:UCr ratio within 1-2 weeks
• BP monitoring + outpatient PCP follow-up

For Moderate/Significant Proteinuria (≥ 3+ or UPr:UCr > 0.2, Rosen's + Harriet Lane Box 19.2)

7. Management (Rosen's EM + Harriet Lane)

Step 1 - Confirm Proteinuria

Step 2 - Rule out Orthostatic Proteinuria

• First morning void: if negative while first morning void is normal -> orthostatic; no further workup needed
• If positive on first morning void -> fixed proteinuria; proceed with evaluation

Step 3 - Stratify by Severity

Step 4 - Admission Indications (Rosen's EM)

• Edema or ascites
• Hypertension > 99th percentile for age/sex/height
• Renal dysfunction (BUN or creatinine elevated > 50% of normal)
• New-onset nephrotic syndrome (most require inpatient; some mild cases outpatient with nephrology guidance)

Step 5 - Treatment of Nephrotic Syndrome (most common cause: Minimal Change Disease)

• Prednisolone 2 mg/kg/day (max 60 mg/day) for 4-6 weeks, then alternate-day dosing
• Fluid restriction for severe edema
• Salt restriction
• Low-dose furosemide for symptomatic edema (with nephrology guidance)
• Monitor for infections (susceptibility to encapsulated organisms due to immunoglobulin loss)
• Pneumococcal vaccination

8. Disposition (Rosen's EM)

• All children with proteinuria - require PCP follow-up with BP monitoring and repeat UA
• Moderate/significant proteinuria - pediatric nephrology consult for renal biopsy decision
• Renal biopsy indicated in: steroid-resistant nephrotic syndrome, age <1 year or >10 years at onset, hematuria + proteinuria, low complement, systemic features

Key Pearls

1. Orthostatic proteinuria is the most common cause in school-age children - a first morning UPr:UCr is the single most important test to rule it out
2. UPr:UCr > 2.0 = nephrotic range in children over 2 years
3. Minimal change disease accounts for ~90% of idiopathic nephrotic syndrome in ages 1-10 years
4. Proteinuria + low C3 = think post-streptococcal GN or lupus
5. Proteinuria + rash + joint pain = think lupus nephritis or HSP
6. Opioids, NSAIDs, aminoglycosides are tubular toxins - always check medication history